SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
1. Faruqi & Faruqi is investigating claims against Iovance Biotherapeutics. 2. Class action alleges Iovance misrepresented its growth potential. 3. Iovance's stock fell 44.8% following poor financial guidance. 4. Investors can seek lead plaintiff role by July 14, 2025. 5. Investors are urged to contact the law firm for more information.